Neurons, neural stem cells, and other slowly dividing cells are notoriously difficult to transfect. With CRISPR-based gene editing gaining momentum, transfection is an essential technique in the modern laboratory. Hear from Polyplus Transfection about the challenges of transfection, and their unique solution to this common problem. www.polyplus-transfection.com
Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.